Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment-Reference-Cited by-同舟云学术

Inactivation of severe acute respiratory syndrome coronavirus 2 in plasma and platelet products using a riboflavin and ultraviolet light‐based photochemical treatment

Published:2020-05-14 Issue:6 Volume:115 Page:495-501
ISSN:0042-9007
Container-title:Vox Sanguinis
language:en
Short-container-title:Vox Sang

Author:

Keil Shawn D.¹^ORCID,Ragan Izabela²,Yonemura Susan¹,Hartson Lindsay³,Dart Nicole K.¹,Bowen Richard²

Affiliation:

1. Terumo BCT Lakewood CO USA

2. Department of Biomedical Sciences Colorado State University Fort Collins CO USA

3. Infectious Disease Research Center Colorado State University Fort Collins CO USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/vox.12937

Reference42 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019

2. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

3. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

4. SARS and MERS: recent insights into emerging coronaviruses

5. Recently Discovered Human Coronaviruses

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Photoinactivation of Bacterial Isolated from Blood Donors Skin: Potential of Security Barrier in Transfusional Therapy;Pathogens;2024-07-11

2. Photoactivated riboflavin inhibits planktonic and biofilm growth of Candida albicans and non-albicans Candida species;Microbial Pathogenesis;2024-06

3. The Role of Vitamins, Magnesium, and Trace Elements in COVID-19 Treatment and Post-COVID-19 Rehabilitation: An Updated Overview;Current Medicinal Chemistry;2024-05-20

4. Significance of Vitamin Supplementation in Reducing the Severity of COVID-19;Mini-Reviews in Medicinal Chemistry;2024-02

5. Viral agents (2nd section);Transfusion;2024-02